SHAREHOLDERS' EQUITY - Derivative Liability for Authorized Share Deficiency (Details) - USD ($) $ in Thousands |
9 Months Ended | |||||
|---|---|---|---|---|---|---|
Feb. 17, 2021 |
Mar. 31, 2021 |
Mar. 31, 2022 |
Jun. 30, 2021 |
Mar. 26, 2021 |
Feb. 16, 2021 |
|
| DERIVATIVE LIABILITY FOR AUTHORIZED SHARE DEFICIENCY | ||||||
| Common stock, shares authorized | 10,000,000 | 40,000,000 | 40,000,000 | 40,000,000.0 | 500,000,000 | |
| Common stock, shares issued | 8,352,000 | 15,556,000 | 8,352,000 | |||
| Common stock, shares outstanding | 8,352,000 | 15,556,000 | 8,352,000 | |||
| Shares reserved for issuance | 2,428,000 | |||||
| Shares subject to the deficiency, required to settle in cash | 780,000 | 740,000 | ||||
| Authorized share deficiency | 780,000 | 740,000 | 740,000 | |||
| Fair value of stock options and warrants | $ 3,591 | $ 1,800 | $ 1,807 | |||
| Share were required to be authorized | 118,000 | |||||
| Number of stock options expired | 780,000 | |||||
| Expiration of stock options and warrants | 780,000 | 40,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of stock options and warrants expired. No definition available.
|
| X | ||||||||||
- Definition Represents the number of shares subject to the deficiency, required to settle in cash. No definition available.
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares that would be issued, determined under the conditions specified in the contract, if the settlement were to occur at the reporting date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|